Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/08 → 12/31/08 |
Funding
- Allergan Pharmaceuticals Inc: $3,916.00
A 6 Day, Phase 3, Multicenter, Randomized, Double-Masked, Parallel Study to Compare the Safety and Efficacy of Gatifloxacin 0.5% Ophthalmic Solution BID with that of Vehicle in the Treatment of Acute Bacterial Conjunctivitis
- Capoor, Seema (PI)